Actavis products are generally subject to the rigorous approval process of the United States Food and Drug Administration, also known as the FDA. For pharmaceuticals, including those produced by Actavis, the FDA evaluates the safety, efficacy, and manufacturing quality before granting approval for marketing in the United States. This applies to both brand-name drugs and generic products produced by Actavis.
When a new drug or formulation is developed, Actavis must submit a New Drug Application or an Abbreviated New Drug Application for generics to the FDA, providing comprehensive data from clinical trials and laboratory studies. Once approved, these products can be made available to healthcare providers and patients.
It is also important to note that the specific status of any given product, including whether it has been approved by the FDA, may vary. Therefore, for up-to-date and detailed information about the approval status of Actavis products, individuals are encouraged to visit the official www.allergan.com website or consult relevant resources.